Publication: Success of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
| dc.authorwosid | Baskin, Esra/B-5785-2018 | |
| dc.authorwosid | Bayrakci, Umut/Ncv-3032-2025 | |
| dc.authorwosid | Gulleroglu, Kaan/Aaj-8833-2021 | |
| dc.authorwosid | Yilmaz, Ebru/Aax-2436-2021 | |
| dc.authorwosid | Ozkaya, Ozan/Aao-2136-2020 | |
| dc.contributor.author | Kantar, Asli | |
| dc.contributor.author | Gulleroglu, Kaan | |
| dc.contributor.author | Bayrakci, Umut | |
| dc.contributor.author | Ozkaya, Ozan | |
| dc.contributor.author | Ozcan, Ebru | |
| dc.contributor.author | Baskin, Esra | |
| dc.date.accessioned | 2025-12-11T00:48:35Z | |
| dc.date.issued | 2013 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Kantar, Asli; Gulleroglu, Kaan; Bayrakci, Umut; Ozcan, Ebru; Baskin, Esra] Baskent Univ, TR-06490 Ankara, Turkey; [Ozkaya, Ozan] Ondokuz Mayis Univ, Ankara, Turkey | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.endpage | 1572 | en_US |
| dc.identifier.issn | 0931-041X | |
| dc.identifier.issue | 8 | en_US |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 1572 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/39461 | |
| dc.identifier.volume | 28 | en_US |
| dc.identifier.wos | WOS:000321387203115 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.relation.ispartof | Pediatric Nephrology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Success of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
